2
Clinical Trials associated with CD123 CAR-T cell therapy(Chongqing Precision Biotech Co., Ltd)Safety and Efficacy of CD123-Targeted CAR-T Therapy for Relapsed/Refractory Acute Myeloid Leukemia
This is a single arm study to evaluate the efficacy and safety of CD123-targeted CAR-T cells therapy for patients with relapsed/refractory Acute Myeloid Leukemia.
CD123-Targeted CAR-T Cell Therapy for Relapsed/Refractory Acute Myeloid Leukemia
There are limited options for treatment of relapse/refractory acute myeloid leukemia (AML). CD123 CAR-T cells may have an attractive and permanent effect on anti-tumor. This study purpose to estimate the safety and efficiency of CD123 CAR-T cells to patients with relapse/refractory AML.
100 Clinical Results associated with CD123 CAR-T cell therapy(Chongqing Precision Biotech Co., Ltd)
100 Translational Medicine associated with CD123 CAR-T cell therapy(Chongqing Precision Biotech Co., Ltd)
100 Patents (Medical) associated with CD123 CAR-T cell therapy(Chongqing Precision Biotech Co., Ltd)
100 Deals associated with CD123 CAR-T cell therapy(Chongqing Precision Biotech Co., Ltd)